<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Animalcare Group Plc — News on 6ix</title>
<link>https://6ix.com/company/animalcare-group-plc</link>
<description>Latest news and press releases for Animalcare Group Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 09:04:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/animalcare-group-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835e07778dffbe2df126045.webp</url>
<title>Animalcare Group Plc</title>
<link>https://6ix.com/company/animalcare-group-plc</link>
</image>
<item>
<title>Form 8.3 - [ANIMALCARE GROUP PLC - 28 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-28-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-28-04-2026-cgwl</guid>
<pubDate>Wed, 29 Apr 2026 09:04:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Form 8.3 - [ANIMALCARE GROUP PLC - 27 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-27-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-27-04-2026-cgwl</guid>
<pubDate>Tue, 28 Apr 2026 08:22:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Form 8.3 - [ANIMALCARE GROUP PLC - 24 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-24-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-24-04-2026-cgwl</guid>
<pubDate>Mon, 27 Apr 2026 08:14:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Form 8.3 - [ANIMALCARE GROUP PLC - 21 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-21-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-21-04-2026-cgwl</guid>
<pubDate>Wed, 22 Apr 2026 09:03:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Form 8.3 - Animalcare Group Plc</title>
<link>https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc</guid>
<pubDate>Wed, 22 Apr 2026 08:00:00 GMT</pubDate>
<description>Downing LLPLEI: 213800G3X76VBG9SB50422 April 2026Form 8.3 re. Animalcare Group Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Downing LLP(b) Owner or controller of interests and short positions disclosed, if different from 1(a):Client funds managed by Downing LLP(c) Name of offeror/offeree in relation to whose relevant secur</description>
</item>
<item>
<title>Form 8.3 - [ANIMALCARE GROUP PLC - 20 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-20-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-20-04-2026-cgwl</guid>
<pubDate>Tue, 21 Apr 2026 08:11:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Form 8.3 - Animalcare Group plc - Octopus Investments</title>
<link>https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-octopus-investments</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-octopus-investments</guid>
<pubDate>Mon, 20 Apr 2026 13:47:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:OCTOPUS INVESTMENTS LTD(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree i</description>
</item>
<item>
<title>Form 8.3 - [ANIMALCARE GROUP PLC - 17 04 2026] - (CGWL)</title>
<link>https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-17-04-2026-cgwl</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/form-83-animalcare-group-plc-17-04-2026-cgwl</guid>
<pubDate>Mon, 20 Apr 2026 08:14:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be</description>
</item>
<item>
<title>Disclosure Table</title>
<link>https://6ix.com/company/animalcare-group-plc/news/disclosure-table-39</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/disclosure-table-39</guid>
<pubDate>Thu, 16 Apr 2026 06:45:00 GMT</pubDate>
<description>The Takeover Panel has updated its Disclosure Table, noting the commencement of an offer period for Animalcare Group plc by CCP Paw 2 Limited, a subsidiary of Charterhouse Capital Partners LLP. This announcement signifies a potential change in control for Animalcare Group plc, with the offeror identified on April 16, 2026. Other companies listed in the table, including Gamma Communications plc, NCC Group plc, 1Spatial plc, Afentra plc, Alternative Income REIT plc, Amedeo Air Four Plus Limited, A</description>
</item>
<item>
<title>Recommended Acquisition of Animalcare Group plc</title>
<link>https://6ix.com/company/animalcare-group-plc/news/recommended-acquisition-of-animalcare-group-plc</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/recommended-acquisition-of-animalcare-group-plc</guid>
<pubDate>Thu, 16 Apr 2026 06:00:00 GMT</pubDate>
<description>CCP Paw 2 Limited, a subsidiary of Charterhouse Capital Partners, has made a recommended acquisition of Animalcare Group PLC for approximately £235.2 million. The offer provides Animalcare shareholders with 336 pence in cash per share, representing a significant premium to recent trading prices, or an alternative option to reinvest in a new entity. The Animalcare Directors unanimously recommend this acquisition, citing it as a superior outcome compared to remaining an independent public company,</description>
</item>
<item>
<title>Capital Markets Event: In Good Health</title>
<link>https://6ix.com/company/animalcare-group-plc/news/capital-markets-event-in-good-health</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/capital-markets-event-in-good-health</guid>
<pubDate>Wed, 04 Mar 2026 07:00:00 GMT</pubDate>
<description>Animalcare Group Plc is hosting a Capital Markets Event to outline its growth strategy and medium-term financial ambitions, aiming for approximately £150 million in revenue with a pathway to a 25% EBITDA margin by 2030. This strategy leverages recent acquisitions like Randlab and an expanding R&D pipeline, with plans to accelerate organic growth through investments in its dental franchise, manufacturing efficiency, and selective acquisitions. The company has undergone a transformation over the p</description>
</item>
<item>
<title>Notification of major holdings</title>
<link>https://6ix.com/company/animalcare-group-plc/news/notification-of-major-holdings-6</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/notification-of-major-holdings-6</guid>
<pubDate>Thu, 22 Jan 2026 17:54:00 GMT</pubDate>
<description>Octopus Investments Limited has increased its holding in Animalcare Group PLC, now controlling 4.07% of the company's voting rights, which equates to 2,813,479 shares. This represents an increase from their previous notification where they held 3.01% of the voting rights. The acquisition occurred on January 20, 2026, and was notified to the issuer on January 21, 2026.
Disclaimer*</description>
</item>
<item>
<title>Trading Update & Notice of Capital Markets Event</title>
<link>https://6ix.com/company/animalcare-group-plc/news/trading-update-and-notice-of-capital-markets-event</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/trading-update-and-notice-of-capital-markets-event</guid>
<pubDate>Thu, 22 Jan 2026 12:00:00 GMT</pubDate>
<description>Animalcare Group Plc reported a strong financial performance for the year ended 31 December 2025, with revenue increasing 20% to approximately £89.1 million, driven by the successful integration of Randlab and growth in flagship brands like Daxocox and its dental portfolio. Underlying EBITDA saw a significant increase of approximately 50% compared to the prior year, with cash conversion in line with guidance at around 80%. The company maintained a strong financial position with net debt at £9.1 </description>
</item>
<item>
<title>Notification of Major Holding in Company</title>
<link>https://6ix.com/company/animalcare-group-plc/news/notification-of-major-holding-in-company</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/notification-of-major-holding-in-company</guid>
<pubDate>Mon, 05 Jan 2026 19:34:00 GMT</pubDate>
<description>Harwood Capital LLP has increased its stake in Animalcare Group PLC, crossing a notification threshold on January 2, 2026. The firm now holds 18.0799% of the voting rights, representing 12,483,430 shares, up from a previous holding of 17.8750%. This acquisition was made through its controlled undertakings, Oryx International Growth Fund Limited, Harwood Capital LLP itself, and North Atlantic Smaller Companies Investment Trust Plc.
Disclaimer*</description>
</item>
<item>
<title>Grant of options and PDMR Dealing</title>
<link>https://6ix.com/company/animalcare-group-plc/news/grant-of-options-and-pdmr-dealing</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/grant-of-options-and-pdmr-dealing</guid>
<pubDate>Tue, 23 Dec 2025 12:00:00 GMT</pubDate>
<description>Animalcare Group PLC announced the grant of nil-cost options over 294,222 ordinary shares to Executive Directors and PDMRs under its LTIP, with vesting on 22 December 2028 contingent on EPS growth and Total Shareholder Return over the three years ending 31 December 2027. Specifically, 50% of the award is tied to EPS growth, with 100% vesting at 10% annual growth and 25% vesting at 3% annual growth, and the remaining 50% is linked to TSR ranking against a comparator group, with 100% vesting at up</description>
</item>
<item>
<title>PDMR Dealing</title>
<link>https://6ix.com/company/animalcare-group-plc/news/pdmr-dealing-1</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/pdmr-dealing-1</guid>
<pubDate>Wed, 19 Nov 2025 15:57:00 GMT</pubDate>
<description>Animalcare Group plc announced that Non-Executive Director Dr Douglas Hutchens purchased 7,500 ordinary shares at 249 pence per share on November 19, 2025. Following this transaction, Dr Hutchens' total interest in the company, including associated persons, now comprises 12,500 ordinary shares, representing 0.02% of the total voting rights. This purchase by a director is generally viewed positively by the market as it indicates confidence in the company's future prospects.
Discla</description>
</item>
<item>
<title>Exercise of Options and Total Voting Rights</title>
<link>https://6ix.com/company/animalcare-group-plc/news/exercise-of-options-and-total-voting-rights-1</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/exercise-of-options-and-total-voting-rights-1</guid>
<pubDate>Wed, 19 Nov 2025 12:45:00 GMT</pubDate>
<description>Animalcare Group plc announced the exercise of options under its Long Term Incentive Plan, resulting in the issuance of 56,873 new ordinary shares. These new shares will be admitted to trading on AIM on November 24, 2025, and will rank pari passu with existing shares. Following this issuance, the total number of ordinary shares in issue with voting rights will be 69,045,945, with no shares held in treasury. This figure will serve as the denominator for shareholders calculating their notification</description>
</item>
<item>
<title>Interim Results for six months ended 30 June 2025</title>
<link>https://6ix.com/company/animalcare-group-plc/news/interim-results-for-six-months-ended-30-june-2025</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/interim-results-for-six-months-ended-30-june-2025</guid>
<pubDate>Tue, 30 Sep 2025 11:00:00 GMT</pubDate>
<description>Interim Results for six months ended 30 June 2025.</description>
</item>
<item>
<title>Collaboration to develop treatment for sweet itch</title>
<link>https://6ix.com/company/animalcare-group-plc/news/collaboration-to-develop-treatment-for-sweet-itch</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/collaboration-to-develop-treatment-for-sweet-itch</guid>
<pubDate>Wed, 24 Sep 2025 11:00:00 GMT</pubDate>
<description>Animalcare Group plc has entered into an agreement with 272Bio Limited to develop and commercialize a novel biological treatment for "sweet itch," a common equine skin condition affecting an estimated 8% of horses globally. The collaboration aims to address the significant unmet need for effective treatments in a global market estimated to be worth between €150m and €200m annually. The program is in its early stages, focusing on preclinical research to achieve proof of concept within the next 18</description>
</item>
<item>
<title>Notice of Results & Presentations</title>
<link>https://6ix.com/company/animalcare-group-plc/news/notice-of-results-and-presentations</link>
<guid isPermaLink="true">https://6ix.com/company/animalcare-group-plc/news/notice-of-results-and-presentations</guid>
<pubDate>Tue, 23 Sep 2025 11:00:00 GMT</pubDate>
<description>Animalcare Group PLC will announce its results for the six months ended June 30, 2025, on Tuesday, September 30, 2025. The company will host an analyst presentation at 10:00 am on the same day. Following this, an investor presentation will be held at 4:00 pm on Monday, October 6, 2025.
Disclaimer*</description>
</item>
</channel>
</rss>